Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Tissue Factor-Related Biomarkers and Prediction of Cancer-Associated VTE: Correlative Analyses of the Phacs Trial

Alok A. Khorana, MD, Nigel Mackman, PhD, Yohei Hisada, PhD, Cihan Ay, MD, Derick Peterson, Charles W. Francis, MD, Andrea Baran, MS

Blood (2017) 130 (Supplement 1): 1096.

https://doi.org/10.1182/blood.V130.Suppl_1.1096.1096

Published: 2017

Journal Articles

Thromboembolism and Clinically Relevant Bleeding in Relation to Warfarin Anticoagulation Variability in Patients Monitored with Either Fiix-Prothrombin Time or Quick-Prothrombin Time. the Fiix-Trial

Alma R. Oskarsdottir, BS, Brynja R. Gudmundsdottir, MS, Olafur S. Indridason, MD MPH, Hulda M. Jensdottir, BS, David O. Arnar, MD PhD, Einar S. Bjornsson, MD PhD, Magnus K. Magnusson, MD, Sigrun H. Lund, PhD, Brynjar Vidarsson, MD, Charles W. Francis, MD, Pall T. Onundarson, MD

Blood (2015) 126 (23): 1129.

https://doi.org/10.1182/blood.V126.23.1129.1129

Published: 2015

Journal Articles

Gender Differences during Long-Term Warfarin Anticoagulation in Patients with Atrial Fibrillation Monitored with Fiix-Prothrombin Time or Prothrombin Time. the Fiix Trial

Hulda M. Jensdottir, BS, Brynjar Vidarsson, MD, Brynja R. Gudmundsdottir, MS, Alma R. Oskarsdottir, BS, Olafur S. Indridason, MD MPH, David O. Arnar, MD PhD, Einar S. Bjornsson, MD PhD, Magnus K. Magnusson, MD, Sigrun H. Lund, PhD, Charles W. Francis, MD, Pall T. Onundarson, MD

Blood (2015) 126 (23): 1134.

https://doi.org/10.1182/blood.V126.23.1134.1134

Published: 2015

Journal Articles

Monitoring Warfarin with the Fiix-Prothrombin Time Improves Anticoagulation Stability and Long-Term Clinical Outcome. the Fiix-Trial

Pall T. Onundarson, MD, Charles W. Francis, MD, Einar S. Bjornsson, MDPhD, Magnus K. Magnusson, MD, David O. Arnar, MD, Olafur S. Indridason, MD, Sigrun Helga Lund, PhD, Sigurdur J. Juliusson, BS, Hulda M. Jensdottir, Brynja R. Gudmundsdottir, MS

Blood (2014) 124 (21): 347.

https://doi.org/10.1182/blood.V124.21.347.347

Published: 2014

Journal Articles

Critical Role of Factors II and X During Coumarin Anticoagulation and Their Combined Measurement with a New Prothrombin Time Variant (Fiix-PT),

Pall T. Onundarson, MD, Brynja R. Gudmundsdottir, MS, Charles W. Francis, MD

Blood (2011) 118 (21): 3354.

https://doi.org/10.1182/blood.V118.21.3354.3354

Published: 2011

Journal Articles

Pioglitazone Inhibits Platelet Function and Potentiates the Effects of Aspirin

John P. Mongan, DO, Hanna Mieszczanska, MD, Richard P. Phipps, PhD, Charles W. Francis, MD

Blood (2011) 118 (21): 1228.

https://doi.org/10.1182/blood.V118.21.1228.1228

Published: 2011

Journal Articles

A Predictive Risk Score for Cancer-Associated Thrombosis: Role of Screening In A Prospective Study

Alok A. Khorana, M.D., Kimberly Herman, Deborah Rubens, Charles W. Francis, MD

Blood (2010) 116 (21): 3173.

https://doi.org/10.1182/blood.V116.21.3173.3173

Published: 2010

Journal Articles

Low Molecular Weight Heparin Thromboprophylaxis in Ambulatory Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Nicole M. Kuderer, MD, Thomas L. Ortel, MD, PhD, Alok A Khorana, MD, Charles W. Francis, MD, Gary H. Lyman, MD, MPH

Blood (2009) 114 (22): 490.

https://doi.org/10.1182/blood.V114.22.490.490

Published: 2009

Journal Articles

The Effects of Anti-A and Anti-B On Platelet Function: An in Vitro Model of ABO Non-Identical Transfusion.

Majed A. Refaai, MD, Neil Blumberg, MD, Charles W. Francis, MD, Richard Phipps, Sherry Spinelli, Brian Smith, Kelly Gettings

Blood (2009) 114 (22): 2120.

https://doi.org/10.1182/blood.V114.22.2120.2120

Published: 2009

Journal Articles

Venous Thromboembolism Risk Model Predicts Early Progression and Overall Mortality in Cancer Patients Receiving Chemotherapy

Nicole M. Kuderer, MD, Alok A. Khorana, MD, Charles W. Francis, MD, Eva Culakova, PhD, MS, Thomas L. Ortel, MD, PhD, Anna Falanga, MD, Gary H. Lyman, MD, MPH

Blood (2008) 112 (11): 172.

https://doi.org/10.1182/blood.V112.11.172.172

Published: 2008

Journal Articles

High Incidence of Thromboembolic Complications and PF4 Positivity in Patients with Ventricular Assist Devices.

Brandon J. McMahon, MD, Jainulabdeen J. Ifthikharuddin, MD, Elie Dib, MD, Leway Chen, MD, Charles W. Francis, MD, Todd H. Massey, MD

Blood (2006) 108 (11): 4083.

https://doi.org/10.1182/blood.V108.11.4083.4083

Published: 2006

Journal Articles

A Predictive Model for Chemotherapy-Associated Thrombosis Based on Findings from a Prospective Outpatient Registry.

Alok A. Khorana, MD, Charles W. Francis, MD, Eva Culakova, PhD, Rami Komrokji, MD, Nikhil Uppal, MD, Gary H. Lyman, MD

Blood (2004) 104 (11): 2586.

https://doi.org/10.1182/blood.V104.11.2586.2586

Published: 2004

Journal Articles

Thrombocytosis Increases the Risk of Chemotherapy-Associated Thrombosis.

Alok A. Khorana, MD, Charles W. Francis, MD, Eva Culakova, PhD, Gary H. Lyman, MD

Blood (2004) 104 (11): 282.

https://doi.org/10.1182/blood.V104.11.282.282

Published: 2004

Journal Articles

Venous Thromboembolic Events in Patients with Diffuse Large B cell Non- Hodgkin’s Lymphoma.

Rami S. Komrokji, MD, Nikhil P. Uppal, MD, Alok A. Khorana, MD, Gary H. Lyman, MD, MPH.FRCP (Edin), Karen L. Kaplan, MD, Richard I. Fisher, MD, Charles W. Francis, MD

Blood (2004) 104 (11): 4542.

https://doi.org/10.1182/blood.V104.11.4542.4542

Published: 2004

Journal Articles

Incidence and Risk Factors for Thromboembolism in Patients with Hematologic Malignancies Undergoing Allogeneic and Autologous Stem Cell Transplantation.

Nicole M. Kuderer, MD, Alok A. Khorana, MD, Jonathan W. Friedberg, MD, Eva Culakova, PhD, Gordon L. Phillips, MD, Charles W. Francis, MD, Gary H. Lyman, MD, MPH

Blood (2004) 104 (11): 1141.

https://doi.org/10.1182/blood.V104.11.1141.1141

Published: 2004

Journal Articles

Thromboembolism in Hospitalized Neutropenic Cancer Patients.

Alok A. Khorana, MD, Charles W. Francis, MD, Eva Culakova, PhD, Richard I. Fisher, MD, Nicole Kuderer, MD, Gary H. Lyman, MD

Blood (2004) 104 (11): 2199.

https://doi.org/10.1182/blood.V104.11.2199.2199

Published: 2004

Journal Articles

Bleeding Indicators and Wound Complications with Ximelagatran and Warfarin after TKR: Findings from 3 Clinical Trials.

Scott D. Berkowitz, MD, Charles W. Francis, MD, Jennifer McElhattan, MS, Clifford W. Colwell, Jr., MD

Blood (2004) 104 (11): 1771.

https://doi.org/10.1182/blood.V104.11.1771.1771

Published: 2004

Journal Articles

Efficacy wnd Bleeding with Ximelagatran and Warfarin after TKR: Pooled Subgroup Analysis of 3 Phase III Trials.

Scott D. Berkowitz, MD, Jennifer McElhattan, MS, Charles W. Francis, MD, Clifford W. Colwell, Jr., MD

Blood (2004) 104 (11): 1777.

https://doi.org/10.1182/blood.V104.11.1777.1777

Published: 2004

NARROW

Tissue Factor-Related Biomarkers and Prediction of Cancer-Associated VTE: Correlative Analyses of the Phacs Trial

Thromboembolism and Clinically Relevant Bleeding in Relation to Warfarin Anticoagulation Variability in Patients Monitored with Either Fiix-Prothrombin Time or Quick-Prothrombin Time. the Fiix-Trial

Gender Differences during Long-Term Warfarin Anticoagulation in Patients with Atrial Fibrillation Monitored with Fiix-Prothrombin Time or Prothrombin Time. the Fiix Trial

Monitoring Warfarin with the Fiix-Prothrombin Time Improves Anticoagulation Stability and Long-Term Clinical Outcome. the Fiix-Trial

Critical Role of Factors II and X During Coumarin Anticoagulation and Their Combined Measurement with a New Prothrombin Time Variant (Fiix-PT),

Pioglitazone Inhibits Platelet Function and Potentiates the Effects of Aspirin

A Predictive Risk Score for Cancer-Associated Thrombosis: Role of Screening In A Prospective Study

Low Molecular Weight Heparin Thromboprophylaxis in Ambulatory Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

The Effects of Anti-A and Anti-B On Platelet Function: An in Vitro Model of ABO Non-Identical Transfusion.

Venous Thromboembolism Risk Model Predicts Early Progression and Overall Mortality in Cancer Patients Receiving Chemotherapy

High Incidence of Thromboembolic Complications and PF4 Positivity in Patients with Ventricular Assist Devices.

A Predictive Model for Chemotherapy-Associated Thrombosis Based on Findings from a Prospective Outpatient Registry.

Thrombocytosis Increases the Risk of Chemotherapy-Associated Thrombosis.

Venous Thromboembolic Events in Patients with Diffuse Large B cell Non- Hodgkin’s Lymphoma.

Incidence and Risk Factors for Thromboembolism in Patients with Hematologic Malignancies Undergoing Allogeneic and Autologous Stem Cell Transplantation.

Thromboembolism in Hospitalized Neutropenic Cancer Patients.

Bleeding Indicators and Wound Complications with Ximelagatran and Warfarin after TKR: Findings from 3 Clinical Trials.

Efficacy wnd Bleeding with Ximelagatran and Warfarin after TKR: Pooled Subgroup Analysis of 3 Phase III Trials.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only